IGF1R and skin squamous cell carcinoma: Treatment with EGFR inhibitor, such as cetuximab, combined with the anti-IGF-IR antibody, has been shown to reduce proliferation and induced apoptosis in cSCC cells in vitro, showing that this approach could be useful for the treatment of cSCC (92).